1. Home
  2. PCB vs ARMP Comparison

PCB vs ARMP Comparison

Compare PCB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$23.38

Market Cap

351.0M

Sector

Finance

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$8.12

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
ARMP
Founded
2003
N/A
Country
United States
United States
Employees
N/A
61
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
351.0M
295.5M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
PCB
ARMP
Price
$23.38
$8.12
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$25.50
$15.00
AVG Volume (30 Days)
17.9K
73.3K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.65%
N/A
EPS Growth
48.28
N/A
EPS
0.74
N/A
Revenue
$2,899,000.00
N/A
Revenue This Year
$13.73
N/A
Revenue Next Year
$9.07
N/A
P/E Ratio
$31.65
N/A
Revenue Growth
4.51
N/A
52 Week Low
$19.28
$1.74
52 Week High
$25.15
$14.98

Technical Indicators

Market Signals
Indicator
PCB
ARMP
Relative Strength Index (RSI) 43.48 37.96
Support Level $21.12 $7.43
Resistance Level $24.25 $12.11
Average True Range (ATR) 0.50 1.32
MACD -0.17 -0.23
Stochastic Oscillator 7.85 11.97

Price Performance

Historical Comparison
PCB
ARMP

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: